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Background:  Many patients with diabetes have relatively normal levels of LDL cholesterol (LDL-C) yet have increased numbers of other 
atherogenic lipoproteins. Differences in lipoprotein subclasses with type 2 diabetes (T2DM) who have achieved very low levels of LDL-C (Less than 
50 mg/dL) have not been extensively examined.
Objective: The aim of this study was to assess variations in lipids, lipoprotein particle concentration in diabetic patients.
Methods:  Data were selected from a large single laboratory database. Cases were patients with a T2DM diagnosis code. Lipoprotein particle 
concentrations were analyzed by nuclear magnetic resonance (NMR) spectroscopy. Lipids were measured at a central laboratory certified for lipid 
analysis by the Standardization Program of the Centers for Disease Control.
Results:  Among the 1,970 patients with T2DM, the mean age was 60.62 for males and 63.22 for females (51.2% male). At LDL-C concentrations 
of less than 50 mg/dL (triglyceride less than 150 mg/dL and high-density lipoprotein cholesterol (HDL-C) greater than 40 mg/dL), the LDL-P 
concentration distributions were 41% less than 700 nmol/L, 45% between 700 to 1000 nmol/L, 12% between 1001 to 1300 nmol/L, and 2% 
greater than 1301 nmol/L.
Conclusion: Despite attainment of LDL cholesterol goals less than 50 mg/dL, these patients retained considerable residual coronary heart disease 
risk, with 59% of them having LDL-P concentration greater than 700 nmol/L.
